Welcome! Click course links to visit the site sponsoring the free CME courses for Physicians. All courses are FREE & approved for AMA Pra CAT 1 credit required for Physician license renewal in most states. Posts are current and include expiration dates if applicable.

T2D:Benefits & Risks of Tight Glycemic Control

Identifying the Pathway to Successful Patient Care: Practical Implementation of Incretin-Based Therapies in Type 2 Diabetes- Evaluate the benefits and risks of intensive glycemic control in T2D. Explain the rationale for incretin-based therapies. Compare and contrast the mechanism of action and modalities between GLP-1 receptor agonists and DPP-4 inhibitors. Recognize and differentiate between the administration routes, efficacy, and potential nonglycemic benefits associated with GLP-1 receptor agonists and DPP-4 inhibitors. Outline the safety considerations for GLP-1 receptor agonists and DPP-4 inhibitors. Discuss the need for patient education regarding the use of GLP-1 receptor agonists and DPP-4 inhibitors

1.5 Free AMA Pra CAT 1 CME for Physicians